Rishikesh K, Saravu K. Severe vivax malaria: a prospective exploration at a tertiary healthcare centre in Southwestern India. Pathog Glob Health. 2017;111(3):148–160.
https://doi.org/10.1080/20477724.2017.1309342.
When the above article was published online, the references 55, 56, 60 and 70 were placed incorrectly in the reference list.
The incorrect references are:
[55] Barber BE, William T, Grigg MJ, et al. A prospective comparative study of knowlesi, falciparum, and vivax malaria in Sabah, Malaysia: high proportion with severe disease from Plasmodium knowlesi and Plasmodium vivax but no mortality with early referral and artesunate therapy. Clin Infect Dis. 2013;56(3):383–397.
[56] Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. Blood. 2003;101(9):3407–3412.
[60] Ganguly S, Saha P, Guha SK, et al. High prevalence of asymptomatic malaria in a tribal population in eastern India. J Clin Microbiol. 2013;51(5):1439–1444.
[70] Singh R, Godson II, Singh S, et al. High prevalence of asymptomatic malaria in apparently healthy schoolchildren in Aliero, Kebbi state, Nigeria. J Vector Borne Dis. 2014;51(2):128–132.
The corrected references are now:
[55] Kurtis JD, Mtalib R, Onyango FK, Duffy PE. Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect Immun. 2001 Jan;69(1):123–8.
[56] Leenstra T, ter Kuile FO, Kariuki SK, Nixon CP, Oloo AJ, Kager PA, et al. Dehydroepiandrosterone sulfate levels associated with decreased malaria parasite density and increased hemoglobin concentration in pubertal girls from western Kenya. J Infect Dis. 2003 Jul 15;188(2):297–304.
[60] Siqueira AM, Lacerda MV, Magalhaes BM, Mourao MP, Melo GC, Alexandre MA, et al. Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India. BMC medicine. 2015 Mar 20;13:57.
[70] Singh AK, Khan MS, Khan FA. Prescribing Pattern of Anti-malarial Drugs with Particular Reference to the use of Artesunate in Complicated Plasmodium Vivax Cases. J Clin Diagn Res. 2014 Dec;8(12):HC24-c7.
This has now been amended in the online version.
The authors apologise for this error.